Press Releases

The SCOTUS decision represents a departure from judicial and PTO precedent supporting patentability of DNA molecules. The decision could create business uncertainty for a range of inventions.

There are several aspects of this report that deserve further scrutiny.

BIO and Delaware Biocommend the State Senate for introducing legislation designed to  address the regulatory issues related to the interchangeability of biological medicines.

Reps. Marcy Kaptur (D-Ohio), Bruce Braley (D-Iowa) and 11 original co-sponsors introduced the Rural Energy Investment Act, to provide robust mandatory funding and extend eligibility to renewable chemicals in Farm Bill renewable energy and energy efficiency programs.

The 2013 BIO World Congress on Industrial Biotechnology this June 16-19 in Montreal, Canada at the Palais des congrès de Montréal will mark the event’s 10th anniversary. 

The industrial biotech sector supports reform of the Toxic Substances Control Act that promotes innovation in renewable chemicals, which consumers can be confident are cleaner, healthier and safer.

Rx Response elevates to Alert status to address potential impact from Moore tornado on supply chain.

BIO welcomes the opportunity to comment on EPA's proposed amendments and clarifications to the Renewable Fuel Standard. BIO will work with EPA to finalize new pathways for advanced and cellulosic biofuels, which are needed to meet the goals of the RFS.

House Agriculture Committee Democrats, led by Rep. Tim Walz (D-Minn.), offered an amendment to the Farm Bill that would provide mandatory funding to energy title programs.

In a bipartisan vote, the Senate Agriculture, Nutrition and Forestry committee passed a Farm Bill that included robust mandatory funding for energy programs and eligibility for renewable chemicals.

BIO welcomes the unanimous Supreme Court decision in Bowman v. Monsanto, in which the Court confirms that biotechnology seed is entitled to the same protections as other inventions under the patent law.